Showing results (141-150 of 248) with videos related to

Sort By:
Pageof 25
Cell Calcium|December 22, 2005
Non-sense mutations in the dihydropyridine receptor beta1 gene, CACNB1, paralyze zebrafish relaxed mutantsWeibin Zhou, Louis Saint-Amant, Hiromi Hirata, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 8, 2020
Iron kinetics following treatment with sucroferric oxyhydroxide or ferric citrate in healthy rats and models of anaemia, iron overload or inflammationJürgen Floege, Felix Funk, Markus Ketteler, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 26, 2016
Iron-related parameters in dialysis patients treated with sucroferric oxyhydroxideAdrian C Covic, Jürgen Floege, Markus Ketteler, et al.
Emerging Infectious Diseases|October 19, 2005
Characterizing vancomycin-resistant enterococci in neonatal intensive careC Rebecca Sherer, Bruce M Sprague, Joseph M Campos, et al.
American Journal of Nephrology|July 20, 2016
Pharmacodynamic Effects of Sucroferric Oxyhydroxide and Sevelamer Carbonate on Vitamin D Receptor Agonist Bioactivity in Dialysis PatientsStuart M Sprague, Adrian C Covic, Jürgen Floege, et al.
Transplantation|October 27, 2004
Calcium and calcitriol prophylaxis attenuates posttransplant bone lossMichelle A Josephson, L Philip Schumm, May Y Chiu, et al.
The Journal of Urology|December 13, 2016
Prediction of Clinical Outcomes in Prenatal Hydronephrosis: Importance of Gravity Assisted DrainageRachael D Sussman, Emily S Blum, Bruce M Sprague, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 2, 2008
Management of secondary hyperparathyroidism in stages 3 and 4 chronic kidney diseaseDennis L Andress, Daniel W Coyne, Kamyar Kalantar-Zadeh, et al.
Pageof 25